Gauri Sabnis - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gauri Sabnis

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Breast Cancer Research and Treatment|August 11, 2012

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancerRabia A Gilani, Armina A Kazi, Preeti Shah, et al.

Breast Cancer Research : BCR|January 30, 2014

Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancerArmina A Kazi, Rabia A Gilani, Amanda J Schech, et al.

Science Translational Medicine|July 24, 2015

The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disordersLaszlo Prokai, Vien Nguyen, Szabolcs Szarka, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Breast Cancer Research and Treatment|August 11, 2012

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancerRabia A Gilani, Armina A Kazi, Preeti Shah, et al.

Breast Cancer Research : BCR|January 30, 2014

Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancerArmina A Kazi, Rabia A Gilani, Amanda J Schech, et al.

Science Translational Medicine|July 24, 2015

The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disordersLaszlo Prokai, Vien Nguyen, Szabolcs Szarka, et al.

Pageof 4